The United Kingdom diagnostic imaging market size is projected to expand at a high CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the increase in the incidence of chronic illnesses, and a growth in the elderly population.
According to national official statistics provided to Eurostat and the OECD, on 5 March 2019, 24.4 percent of the UK population was at risk due to a history of at least one underlying health condition, including 8.3 percent of school-aged children, 19.6 percent of working-age adults, and 66.2 percent of people aged 70 and up. Multimorbidity affected 7.1% of the population.
The number of persons in England with one chronic condition is expected to remain largely steady over the next ten years. Those with numerous chronic health issues, on the other hand, are expected to increase to 2.9 million in 2018 from 1.9 million in 20083.
According to the Scottish Health Survey, 46 percent of individuals aged 16 and over have at least one chronic health condition, and the prevalence rises with age, from 25 percent of adults aged 16-24 to 77 percent of those aged 75 and over4. However, those under the age of 65 are more likely to have multimorbidity in Scotland than people over the age of 655.
The National Health Service (NHS) in the United Kingdom (UK) covers the whole population and is funded by general taxes and managed by the Department of Health. However, responsibility for purchasing health care services in the United Kingdom is devolved at the component nation level, with Primary Care Trusts in England, Health Boards in Scotland, local health groups in Wales, and Primary Care Partnerships in Northern Ireland.
According to our new data, one in every ten adults over the age of 40 in the UK currently has Type 2 diabetes. According to the new numbers, there are 3.8 million people in the UK who have diabetes, with Type 2 accounting for 90% of those.
There are about 1 million more persons living with Type 2 diabetes who are unaware of their condition because they have not been diagnosed, increasing the total to 4.7 million. This figure is expected to climb to 5.5 million by 2030.
CT scans are increasingly being used as a first-line diagnostic tool for illnesses such as coronary artery disease, as well as in preventative treatment and early detection, such as lung cancer screening.
Recently some of the most notable trends in the diagnostic imaging market has been witness which helps in increasing the share market such as hybrid imaging technology which provide structural as well as functional information in just one examination, another is imaging systems that use lower doses of ionizing radiation decreasing the detrimental effects of radiation on patients.
Developments in magnetic resonance imaging (MRI) techniques, such as the development of superconducting (SC) magnets, high-field MRI, open architecture, and software applications are inviting attentions of manufactures and consumers. Furthermore, the introduction of MRI-compatible pacemakers will greatly expand the number of patients who will be eligible for MRI operations.
The COVID-19 epidemic has had both beneficial and detrimental effects on the market. One of the negative consequences is that hospitals, particularly small-scale hospitals and imaging centers, have extremely restricted purchasing capability. On the other hand, advanced medical imaging equipment, such as chest X-rays and computed tomography, give useful information about COVID-19, has soon a sharp rise in the demand.
Market Trends, Drivers, Restraints, and Opportunities
- Insurance coverage policies of elderly population is anticipated to be boost the market growth in coming years.
- Government partnership with local manufactures to improved diagnostic imaging services in remote locations is expected to drive the market.
- Improving healthcare infrastructure and rising diagnostic center are projected to push the market growth in the coming years.
- Artificial intelligence and IOT devices enable monitoring and testing is estimated to propel the market expansion.
- Rapid growth of the healthcare industry is key factors spurring the market growth in the coming years.
- Expensive cost of diagnosis process acts as key challenges that can hamper the market growth.
- Ultrasound procedure are highly operator dependent is expected to impede the market expansion.
- R&D investment and technological advancement imaging and software are expected to create significant opportunities for the market players.
Scope of Diagnostic Imaging Market Report
The report on the United Kingdom diagnostic imaging market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
United Kingdom Diagnostic Imaging Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2020
|
|
Historic Data
|
2018–2019
|
|
Forecast Period
|
2021–2028
|
|
Segmentation
|
Applications (Orthopedic, Gastroenterology, Gynecology, Cardiology, Oncology, and Neurology), Modality (Ultrasound, X-Ray, MRI, Computed Tomography, Nuclear Imaging, Fluoroscopy, and Mammography), End Users (Hospitals, Diagnostic Centers, and Others)
|
|
Country Scope
|
United Kingdom
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
Koninklijke Philips N.V.; GE Healthcare; Siemens Healthineers; Carestream Health Inc.; Fujifilm Holdings Corporation
|
United Kingdom Diagnostic Imaging Market Segment Insights
The cardiology segment is projected to constitute a large market share
Based on applications, the United Kingdom diagnostic imaging market is divided into orthopedic, gastroenterology, gynecology, cardiology, oncology, and neurology. The cardiology segment is expected to represent a key share of the market during the forecast period owing to rising demand for cardiac arrhythmia monitoring devices among individual to track and manage their own health.
The magnetic resonance imaging (MRI) segment is expected to grow at a robust pace
On the basis of modality, the United Kingdom diagnostic imaging market is segmented into ultrasound, x-ray, mri, computed tomography, nuclear imaging, fluoroscopy, and mammography. The magnetic resonance imaging (MRI) segment is expected to represent a key share of the market in the coming years due to increasing technological developments in the MRI spectrum and expanding the use of MRI in healthcare.
The diagnostic centers segment is anticipated to register rapid CAGR
In terms of end users, the United Kingdom diagnostic imaging market is divided into hospitals, diagnostic centers, and others. The diagnostic centers segment is expected to hold a key share of the market during the forecast period owing to growing specialty centers also increasing number of medical tourists for diagnosis and treatments in the country.
Segments
The global United Kingdom diagnostic imaging market has been segmented on the basis of
Applications
- Orthopedic
- Gastroenterology
- Gynecology
- Cardiology
- Oncology
- Neurology
Products
- Nuclear Medicine
- Fluoroscope
- Mammography
- X-ray
- Ultrasound
- Magnetic Resonance Imaging (MRI)
- Computed Tomography
End Users
- Hospitals
- Diagnostic Centers
- Others
Country
Key Players
Competitive Landscape
Key players competing in the United Kingdom diagnostic imaging market include Koninklijke Philips N.V.; GE Healthcare; Siemens Healthineers; Carestream Health Inc.; Fujifilm Holdings Corporation.
Some of these players are coming with several market strategies including as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to increase their market shares.
Request For Customization
Enquiry Before Buying
Speak With Analyst
